Strategy for
High-Value Startups:
Automating the
Pre-Commercial Exit
Strategy for High-Value Startups
The Venture Factory – Automating the pre-commercial exit
On Demand recording of Automating the pre-commercial exit as a strategy for high-value startups presented by Amr Salahieh, serial entrepreneur and founder of Sadra Medical and Shifamed, at Medical Device Playbook Newport Beach 2024 is now available for on demand viewing.
With over 100 patents and a 20-year history of taking med-device companies from start-up to exit, Amr shares insights on automating the pre-commercial exit as a strategy for high-value startups.shares his hard-earned insights on automating the pre-commercial exit as a strategy for high-value startups.
Amr’s strategy for high-value startups includes:
- Innovation Hub
- Diversity Portfolio
- Large Markets
- Engineering the Future
- Capitalize on Trends
- Focused Expertise
- Strategy for High-Value Startups
Presenter Bio
Amr Salahieh
Amr is a seasoned medical device entrepreneur with over 30 years of healthcare experience. He is the founder and CEO of Shifamed LLC, a successful and well-established medical innovation hub headquartered in the heart of Silicon Valley. Legacy portfolio companies that Amr has held a leadership role in include Embolic Protection Inc. (acquired by Boston Scientific, 2001), Sadra Medical (acquired by Boston Scientific, 2011), Maya Medical (acquired by Covidien, 2012), Kalila Medical (acquired by Abbott, 2016), Apama Medical (acquired by Boston Scientific, 2017) and NuVera Medical (acquired by Biosense Webster, a Johnson & Johnson company, 2020).
Shifamed and its dedicated management team have raised over $800M to date for its portfolio companies. Current portfolio companies include five focused in cardiovascular, two in ophthalmology and one enterprise software company. All portfolio companies are founded within Shifamed, with Amr serving as the Chairman of the Board. Each company is an independent Delaware entity led by an experienced CEO or General Manager, with a focused team and strategically structured for rapid integration upon acquisition. To date, Shifamed has grown to over 350 employees across its nine-building campus and over 50 OUS employees.
Amr is the inventor or co-inventor on over 400 issued and pending patent applications worldwide. He holds a B.S. in Biomedical Engineering and a B.S. in Electrical Engineering from Case Western Reserve University.
Medical Device Playbook is one of North America’s largest MedTech events for entrepreneurial companies and medical device professionals. Designed to inform and inspire medtech and biotech entrepreneurs, Playbook brings you stories and insights from some of the industry’s most remarkable entrepreneurs and seasoned experts.
StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.
StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.
Empowering MedTech Innovation®. www.starfishmedical.com
Contact Patrick Dean, Director of Marketing, for media inquiries.